These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7388792)

  • 41. An intramolecular cyclization reaction is responsible for the in vivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin.
    Lee CC; Cramer AT; Szoka FC; Fréchet JM
    Bioconjug Chem; 2006; 17(5):1364-8. PubMed ID: 16984149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
    Jia ZP; Wang R; Xie JW; Xu LT
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells.
    Pang LP; Huang W; Sun Q; Guo W; Li RT; Cui JR
    Anticancer Drugs; 2008 Feb; 19(2):167-74. PubMed ID: 18176113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor activity of L-canavanine against L1210 murine leukemia.
    Green MH; Brooks TL; Mendelsohn J; Howell SB
    Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides.
    Peter G; Hohorst HJ
    Cancer Chemother Pharmacol; 1979; 3(3):181-8. PubMed ID: 527208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
    Narla RK; Chen CL; Dong Y; Uckun FM
    Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New water-soluble duocarmycin derivatives: synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups.
    Amishiro N; Nagamura S; Kobayashi E; Gomi K; Saito H
    J Med Chem; 1999 Feb; 42(4):669-76. PubMed ID: 10052974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of structure to antitumor activities of five derivatives of a beta-glucan from Poria cocos sclerotium.
    Wang Y; Zhang L; Li Y; Hou X; Zeng F
    Carbohydr Res; 2004 Oct; 339(15):2567-74. PubMed ID: 15476718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
    Tzai TS; Lin JS; Chow NH
    J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors.
    Kagawa Y; Noge I; Higashigawa M; Komada Y
    Biol Pharm Bull; 2008 Jan; 31(1):57-61. PubMed ID: 18175942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data.
    Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
    Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
    Peter G; Wagner T; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):429-35. PubMed ID: 1277218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical and biological evaluation of hydrolysis products of cyclophosphamide.
    Gilard V; Martino R; Malet-Martino MC; Kutscher B; Müller A; Niemeyer U; Pohl J; Polymeropoulos EE
    J Med Chem; 1994 Nov; 37(23):3986-93. PubMed ID: 7966159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute toxicity of methotrexate and cyclophosphamide in mice inoculated with malignant neoplasms.
    Graczyk J
    Pol J Pharmacol Pharm; 1981; 33(1):73-80. PubMed ID: 7255281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemically stable N-methyl-4-(alkylthio)cyclophosphamide derivatives as prodrugs of 4-hydroxycyclophosphamide.
    Moon KY; Shirota FN; Baturay N; Kwon CH
    J Med Chem; 1995 Mar; 38(5):848-51. PubMed ID: 7877150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nitroxyl derivatives of rubomycin].
    Emanuél' NM; Konovalova NP; D'iachkovskaia RF; Denisova LK
    Antibiotiki; 1982 Nov; 27(11):811-5. PubMed ID: 7181462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.